Psychological response to cervical screening

Preventive Medicine
S BellE Mann

Abstract

Few studies have examined the psychological costs of cervical screening, despite expressed concern over possible negative sequelae. Seventy-five women with mild or moderately dyskaryotic smears, under cytological surveillance, 75 women referred for colposcopy after a first-ever abnormal smear showing severe dyskaryosis, and 75 controls with recent negative cytology were interviewed at home, and their psychological adjustment was assessed. Levels of distress were higher among women with an abnormal smear than among controls with a recent negative smear. Anxiety (Hospital Anxiety and Depression Scale range 0-21, "normal" range 0-7) was highest among those referred for colposcopy (mean 8.12, controls 5.88, P < 0.001); afterward, distress fell (mean 6.61, P < 0.001) but more problems of social adjustment were evident (surveillance vs controls, P < 0.01). High anxiety was associated with social maladjustment (colposcopy, P < 0.001; surveillance, P < 0.01) and negative feelings about the self (P < 0.05). Current anxiety was unrelated to knowledge about abnormal smears, but in the surveillance group was related to satisfaction with the explanation provided (P < 0.05). A positive cervical smear may by psychologically traumatic for a si...Continue Reading

Citations

Dec 18, 2002·Cytopathology : Official Journal of the British Society for Clinical Cytology·Z PhilipsD K Whynes
May 24, 2001·The New England Journal of Medicine·G F SawayaA M Garber
Apr 27, 2002·Journal of Women's Health & Gender-based Medicine·Mona SaraiyaMatthew T McKenna
Oct 26, 1999·Journal of Women's Health & Gender-based Medicine·M MeanaB Rosen
Mar 11, 2004·Journal of General Internal Medicine·Brenda E Sirovich, H Gilbert Welch
Jan 24, 2012·Journal of the American Medical Informatics Association : JAMIA·Jason S MathiasDavid W Baker
Sep 27, 2005·Journal of Women's Health·Jessica A KahnSusan L Rosenthal
Apr 19, 2007·Journal of Women's Health·Katherine S EgglestonKathryn J Luchok
Jun 19, 2015·European Journal of Cancer Care·S Kola-PalmerM Rogers
Dec 14, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Neerja BhatlaDivya Awasthi
Jun 24, 2015·BJOG : an International Journal of Obstetrics and Gynaecology·M O'ConnorUNKNOWN Irish Cervical Screening Research Consortium (CERVIVA)
Sep 14, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Matejka ReboljElsebeth Lynge
Sep 29, 2009·European Journal of Obstetrics, Gynecology, and Reproductive Biology·C HellstenP G Lindqvist
Sep 11, 2007·Gynecologic Oncology·T MagginoG Altoè
Mar 14, 2016·Cancer Causes & Control : CCC·Steffie K NaberMarjolein van Ballegooijen
Oct 9, 2009·Journal of Evaluation in Clinical Practice·David K Whynes, UNKNOWN TOMBOLA Group
Mar 27, 2004·Sociology of Health & Illness·Anette ForssLisbeth Sachs
Jul 10, 2003·Acta Obstetricia Et Gynecologica Scandinavica·Monica IdeströmAgneta Andersson-Ellström
Jun 5, 2008·Cytopathology : Official Journal of the British Society for Clinical Cytology·D K WhynesUNKNOWN Trial of Management of Borderline and Other Low-grade Abnormal smears Group
Nov 25, 2005·BJOG : an International Journal of Obstetrics and Gynaecology·M E CruickshankJ A S Ross
Mar 24, 2007·BJOG : an International Journal of Obstetrics and Gynaecology·P Martin-HirschB Standaert
Jun 23, 2011·Psycho-oncology·Mélanie DroletJames A Mansi
Jun 11, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·R P de BieR L M Bekkers
Feb 6, 2010·Journal of the American Academy of Nurse Practitioners·Kymberlee Montgomery, Joan Rosen Bloch
Sep 5, 2006·Vaccine·Henry C KitchenerJ Thomas Cox
Jun 13, 2006·Contemporary Clinical Trials·Seonaidh C CottonUNKNOWN TOMBOLA group
Oct 1, 2005·The American Journal of Medicine·Louise C WalterMary B Barton
Sep 10, 2005·Gynecologic Oncology·Sandi L PruittKaren Basen-Engquist
Sep 24, 2015·Psycho-oncology·Mairead O'ConnorUNKNOWN Irish Cervical Screening Research Consortium (CERVIVA)
Jun 9, 2015·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Linda SharpUNKNOWN TOMBOLA Group
Aug 8, 2014·Cytopathology : Official Journal of the British Society for Clinical Cytology·S C CottonUNKNOWN TOMBOLA Group
Jan 13, 2015·Psycho-oncology·Susanna Kola-Palmer, Jane C Walsh
Nov 6, 2013·Journal of Psychosomatic Obstetrics and Gynaecology·Remko P BosgraafRuud L M Bekkers
Jul 24, 2013·Oral Oncology·Carole Fakhry, Gypsyamber D'Souza
Jul 9, 2016·Gynecologic Oncology·Karin A RosenblattJeffrey A Douglas
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer CullenJeanne S Mandelblatt
Apr 20, 2006·British Journal of Cancer·N M GrayUNKNOWN TOMBOLA group
May 26, 2017·Journal of Lower Genital Tract Disease·Nopwaree Chantawong, Kittipat Charoenkwan
Nov 7, 2003·Cancer·Karen Basen-EngquistDiane C Bodurka
Nov 4, 1998·Sexually Transmitted Diseases·J C ShlayJ M Douglas
Feb 26, 2004·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Jo WallerJane Wardle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.